Background illustration for clinical trials search

Paid Clinical Trials Indianapolis

Discover 901 paid clinical trials in Indianapolis, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata

for
Alopecia Areata
Location: Indianapolis IN, Louisville KY, Chicago IL,
Sponsor: AnaptysBio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT05205070

Phase 2, Recruiting

Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes

for
Cancer, Solid Tumor, Hematologic Malignancy
Location: Indianapolis IN, Martinsville IN
Sponsor: Community Cancer Care

Sex: All

Age: 18+

Code: NCT00300001

Recruiting

A Study of IDP-001 in Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Indianapolis IN, Buffalo NY, Lake Success NY,
Sponsor: InduPro, Inc.

Sex: All

Age: 18+

Code: NCT07602842

Phase 1, Phase 2, Recruiting

AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors

for
Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair Deficiency (dMMR),
Location: Indianapolis IN, Zion IL, Nashville TN, Toronto,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07403721

Phase 1, Recruiting

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

for
Solid Cancer
Location: Indianapolis IN, Edgewood KY, Hilliard OH, St Louis MO,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06161025

Phase 2, Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors

for
Locally Advanced/Metastatic Solid Tumors
Location: Indianapolis IN, Nashville TN, Denver CO, New Haven CT,
Sponsor: InSilico Medicine Hong Kong Limited

Sex: All

Age: 18+

Code: NCT06414460

Phase 1, Phase 2, Recruiting

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

for
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors
Location: Indianapolis IN, Cincinnati OH, West Chester OH,
Sponsor: American Society of Clinical Oncology

Sex: All

Age: 12+

Code: NCT02693535

Phase 2, Recruiting

A Study of VET3-TGI in Patients With Solid Tumors

for
Solid Tumor, Adult, Microsatellite Stable Colorectal Cancer,
Location: Indianapolis IN, Pittsburgh PA, Dallas TX, Houston TX,
Sponsor: KaliVir Immunotherapeutics

Sex: All

Age: 18+

Code: NCT06444815

Phase 1, Recruiting

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

for
Functional Mitral Regurgitation, Heart Failure,
Location: Indianapolis IN, Cincinnati OH, Dayton OH, Columbus OH,
Sponsor: Cardiac Dimensions, Inc.

Sex: All

Age: 18+

Code: NCT03142152

Recruiting

A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

for
Colorectal Neoplasms, Gastrointestinal Neoplasms
Location: Indianapolis IN, Grand Rapids MI, Sarasota FL,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06663319

Phase 1, Recruiting

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

for
mCRPC (Metastatic Castration-resistant Prostate Cancer),
Location: Indianapolis IN, Chicago IL, Columbus OH, Maumee OH,
Sponsor: Pathos AI, Inc.

Sex: Male

Age: 18+

Code: NCT06785636

Phase 1, Phase 2, Recruiting

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

for
Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma,
Location: Indianapolis IN, Skokie IL, Nashville TN, Iowa City IA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06324357

Phase 1, Phase 2, Recruiting

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

for
Advanced Cancer, Metastatic Cancer, Ovarian Cancer,
Location: Indianapolis IN, Cincinnati OH, Maumee OH, St Louis MO,
Sponsor: Artios Pharma Ltd

Sex: All

Age: 18+

Code: NCT04657068

Phase 1, Phase 2, Recruiting

GEMINI-NSCLC: NSCLC Biomarker Study

for
Non-Small Cell Lung Cancer
Location: Indianapolis IN, Cincinnati OH, Decatur IL, Columbus OH,
Sponsor: Tempus AI

Sex: All

Age: 18+

Code: NCT05236114

Recruiting

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

for
Solid Tumor, Adult, Refractory Cancer,
Location: Indianapolis IN, Detroit MI, Fairfax VA, New York NY,
Sponsor: GV20 Therapeutics

Sex: All

Age: 18+

Code: NCT05669430

Phase 1, Phase 2, Recruiting

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

for
Ras-mutated Metastatic Colorectal Cancer, mCRC,
Location: Indianapolis IN, Cincinnati OH, Chicago IL, Colombus OH,
Sponsor: Oncolytics Biotech

Sex: All

Age: 18+

Code: NCT07446322

Phase 2, Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

for
Pancreatic Cancer, PDAC,
Location: Indianapolis IN, Maumee OH, Milwaukee WI, Nashville TN,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT07252232

Phase 3, Recruiting

A Study of LY4175408 in Participants With Advanced Cancer

for
Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma,
Location: Indianapolis IN, Chicago IL, Columbus OH, St Louis MO,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07046923

Phase 1, Recruiting

The Fourth Left Atrial Appendage Occlusion Study

for
Atrial Fibrillation, Stroke, Ischemic, Systemic Embolism
Location: Indianapolis IN, Cincinnati OH, Lexington KY,
Sponsor: Hamilton Health Sciences Corporation

Sex: All

Age: 18+

Code: NCT05963698

Recruiting

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

for
Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer,
Location: Indianapolis IN, Grand Rapids MI, Nashville TN,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06128551

Phase 1, Phase 2, Recruiting